Martin Richard John Knapp
← Back to London School of Economics and Political Science
London School of Economics and Political Science
Martin Richard John Knapp works in Health Systems, Economic Evaluations, Quality of Life, Mental Health Treatment and Access, Psychiatric care and mental health services, Healthcare innovation and challenges, Dementia and Cognitive Impairment Research. Recorded institutional associations include University of Exeter, London School of Economics and Political Science.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Resources for mental health: scarcity, inequity, and inefficiency
2007 · 1,787 citationsCost of disorders of the brain in Europe 2010
2011 · 1,718 citationsDefeating Alzheimer's disease and other dementias: a priority for European science and society
2016 · 1,669 citationsSocial isolation, loneliness and health in old age: a scoping review
2015 · 1,450 citationsCosts of Autism Spectrum Disorders in the United Kingdom and the United States
2014 · 1,292 citationsTime for united action on depression: a Lancet–World Psychiatric Association Commission
2022 · 1,053 citationsPoverty and mental disorders: breaking the cycle in low-income and middle-income countries
2011 · 913 citationsFinancial cost of social exclusion: follow up study of antisocial children into adulthood
2001 · 906 citationsWorld Alzheimer Report 2016.Improving healthcare for people living with dementia: Coverage, Quality and costs now and in the future.
2016 · 873 citationsThe Lancet Commission on the future of care and clinical research in autism
2021 · 850 citationsProjections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model
2017 · 839 citationsDonepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
2012 · 780 citationsCosting psychiatric interventions.
1992 · 710 citationsMeasurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology
2005 · 639 citationsThe effectiveness of supported employment for people with severe mental illness: a randomised controlled trial
2007 · 612 citationsEvidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
2005 · 610 citationsEffect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial
2012 · 583 citationsThe worldwide costs of dementia in 2019
2023 · 546 citationsThe Global Costs of Schizophrenia
2004 · 536 citationsSertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
2011 · 532 citationsClient Socio-Demographic and Service Receipt Inventory – European Version: development of an instrument for international research
2000 · 478 citationsExploring barriers to participation and adoption of telehealth and telecare within the Whole System Demonstrator trial: a qualitative study
2012 · 451 citationsTraining carers of stroke patients: randomised controlled trial
2004 · 445 citationsPaying the price: the cost of mental health care in England to 2026
2008 · 437 citationsEconomics and mental health: the current scenario
2020 · 406 citations
